Stay updated on CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.

Latest updates to the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page
- Check7 days agoChange DetectedA glossary toggle and color-coded change indicators were added. The revision note was updated to v3.4.0 and the 'No FEAR Act Data' item was removed.SummaryDifference0.6%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page history shows an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedAddition of Revision: v3.3.3 to the page footer; removal of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.3.2 replaces Revision: v3.2.0 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoval of a site-wide banner about a lapse in government funding and operating status; this change does not affect the trial data, records, or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check100 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments to the Record History page; core study details and statuses appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.